Matrix metalloproteinases and the regulation of tissue remodelling. Page-McCaw A, Ewald AJ, Werb Z (2007) Nat Rev Mol Cell Biol 8: 221-33 Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Guyette WA, Matusik RJ, Rosen JM (1979) Cell 17: 1013-23 Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ (1990) Cell 61: 1147-55 The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance. Huo Y, Macara IG (2014) Nat Cell Biol 16: 529-37 WNT signals are required for the initiation of hair follicle development. Andl T, Reddy ST, Gaddapara T, Millar SE (2002) Dev Cell 2: 643-53 The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J (2008) J Clin Invest 118: 64-78 Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. Stanford JC, Young C, Hicks D, Owens P, Williams A, Vaught DB, Morrison MM, Lim J, Williams M, Brantley-Sieders DM, Balko JM, Tonetti D, Earp HS, Cook RS (2014) J Clin Invest 124: 4737-52 Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Pierce DF, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL (1993) Genes Dev 7: 2308-17 The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. McCaffrey LM, Macara IG (2009) Genes Dev 23: 1450-60 Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. Oliferenko S, Kaverina I, Small JV, Huber LA (2000) J Cell Biol 148: 1159-64 Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM, Arteaga CL (2001) J Cell Biol 153: 917-32 Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6). Wall NA, Blessing M, Wright CV, Hogan BL (1993) J Cell Biol 120: 493-502 The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Ahmed SM, Macara IG (2017) Nat Commun 8: 14867 Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ, Moses HL (1995) Proc Natl Acad Sci U S A 92: 4254-8 The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium. Balko JM, Miller TW, Morrison MM, Hutchinson K, Young C, Rinehart C, Sánchez V, Jee D, Polyak K, Prat A, Perou CM, Arteaga CL, Cook RS (2012) Proc Natl Acad Sci U S A 109: 221-6 TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL (2003) Proc Natl Acad Sci U S A 100: 15548-53 Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Yull F, Harold G, Wallace R, Cowper A, Percy J, Cottingham I, Clark AJ (1995) Proc Natl Acad Sci U S A 92: 10899-903 Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Owens P, Pickup MW, Novitskiy SV, Chytil A, Gorska AE, Aakre ME, West J, Moses HL (2012) Proc Natl Acad Sci U S A 109: 2814-9 Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM (2007) Cancer Res 67: 6760-7 Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Witty JP, Lempka T, Coffey RJ, Matrisian LM (1995) Cancer Res 55: 1401-6 Membrane glycoprotein differences between normal lactating mammary tissue and the R3230 AC mammary tumor. Shin BC, Ebner KE, Hudson BG, Carraway KL (1975) Cancer Res 35: 1135-40 ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis. Cook RS, Garrett JT, Sánchez V, Stanford JC, Young C, Chakrabarty A, Rinehart C, Zhang Y, Wu Y, Greenberger L, Horak ID, Arteaga CL (2011) Cancer Res 71: 3941-51 Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM (2002) Cancer Res 62: 5559-63 Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B (2007) Cancer Res 67: 3135-44 Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL (2005) Cancer Res 65: 2296-302 Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling. Young CD, Pfefferle AD, Owens P, Kuba MG, Rexer BN, Balko JM, Sánchez V, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL (2013) Cancer Res 73: 4075-85 The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Chang SH, Ai Y, Breyer RM, Lane TF, Hla T (2005) Cancer Res 65: 4496-9 Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Clark AJ, Harold G, Yull FE (1997) Nucleic Acids Res 25: 1009-14 TGF-beta in mammary development and neoplasia. Arteaga CL, Moses HL (1996) J Mammary Gland Biol Neoplasia 1: 327-9 ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS (2008) J Mammary Gland Biol Neoplasia 13: 235-46 Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Muraoka-Cook RS, Shin I, Yi JY, Easterly E, Barcellos-Hoff MH, Yingling JM, Zent R, Arteaga CL (2006) Oncogene 25: 3408-23 B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Gregory MA, Xiao Q, Cornwall GA, Lutterbach B, Hann SR (2000) Oncogene 19: 4886-95 Oncogenic suppression of apoptosis uncovers a Rac1/JNK proliferation pathway activated by loss of Par3. Archibald A, Mihai C, Macara IG, McCaffrey L (2015) Oncogene 34: 3199-206 Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE (2011) Oncogene 30: 1402-12 p120-catenin is essential for terminal end bud function and mammary morphogenesis. Kurley SJ, Bierie B, Carnahan RH, Lobdell NA, Davis MA, Hofmann I, Moses HL, Muller WJ, Reynolds AB (2012) Development 139: 1754-64 The winged helix gene, Mf3, is required for normal development of the diencephalon and midbrain, postnatal growth and the milk-ejection reflex. Labosky PA, Winnier GE, Jetton TL, Hargett L, Ryan AK, Rosenfeld MG, Parlow AF, Hogan BL (1997) Development 124: 1263-74 Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Chu EY, Hens J, Andl T, Kairo A, Yamaguchi TP, Brisken C, Glick A, Wysolmerski JJ, Millar SE (2004) Development 131: 4819-29 Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. Keely PJ, Fong AM, Zutter MM, Santoro SA (1995) J Cell Sci 108 ( Pt 2): 595-607 Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors. Ryzhov SV, Pickup MW, Chytil A, Gorska AE, Zhang Q, Owens P, Feoktistov I, Moses HL, Novitskiy SV (2014) J Immunol 193: 3155-64 ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL (2002) Mol Cell Biol 22: 2204-19
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.